A Patient with Genetically Confirmed Myoclonus-Dystonia Responded to Anticholinergic Treatment and Improved Spontaneously
The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission. A 19-year-old g...
Saved in:
| Published in | Journal of clinical neurology (Seoul, Korea) Vol. 7; no. 4; pp. 231 - 232 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
Korean Neurological Association
01.12.2011
대한신경과학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1738-6586 2005-5013 2005-5013 |
| DOI | 10.3988/jcn.2011.7.4.231 |
Cover
| Abstract | The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission.
A 19-year-old girl presented with a 14-year history of myoclonus and dystonia that severely affected her left arm, neck, and trunk. Genetic studies showed a mutation in SGCE [deletion in exon 6 (c.771_772delAT, Cys258X)]. Both myoclonus and dystonia responded to anticholinergic treatment for 7 years and improved spontaneously.
The possibility of spontaneous improvement should be kept in mind when considering the therapeutic strategy in myoclonus-dystonia patients, especially when contemplating deep-brain stimulation. |
|---|---|
| AbstractList | The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission.BACKGROUNDThe various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission.A 19-year-old girl presented with a 14-year history of myoclonus and dystonia that severely affected her left arm, neck, and trunk. Genetic studies showed a mutation in SGCE [deletion in exon 6 (c.771_772delAT, Cys258X)]. Both myoclonus and dystonia responded to anticholinergic treatment for 7 years and improved spontaneously.CASE REPORTA 19-year-old girl presented with a 14-year history of myoclonus and dystonia that severely affected her left arm, neck, and trunk. Genetic studies showed a mutation in SGCE [deletion in exon 6 (c.771_772delAT, Cys258X)]. Both myoclonus and dystonia responded to anticholinergic treatment for 7 years and improved spontaneously.The possibility of spontaneous improvement should be kept in mind when considering the therapeutic strategy in myoclonus-dystonia patients, especially when contemplating deep-brain stimulation.CONCLUSIONSThe possibility of spontaneous improvement should be kept in mind when considering the therapeutic strategy in myoclonus-dystonia patients, especially when contemplating deep-brain stimulation. The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission. A 19-year-old girl presented with a 14-year history of myoclonus and dystonia that severely affected her left arm, neck, and trunk. Genetic studies showed a mutation in SGCE [deletion in exon 6 (c.771_772delAT, Cys258X)]. Both myoclonus and dystonia responded to anticholinergic treatment for 7 years and improved spontaneously. The possibility of spontaneous improvement should be kept in mind when considering the therapeutic strategy in myoclonus-dystonia patients, especially when contemplating deep-brain stimulation. Background The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission. Case Report A 19-year-old girl presented with a 14-year history of myoclonus and dystonia that severely affected her left arm, neck, and trunk. Genetic studies showed a mutation in SGCE [deletion in exon 6 (c.771_772delAT, Cys258X)]. Both myoclonus and dystonia responded to anticholinergic treatment for 7 years and improved spontaneously. Conclusions The possibility of spontaneous improvement should be kept in mind when considering the therapeutic strategy in myoclonus-dystonia patients, especially when contemplating deepbrain stimulation. Background The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission. Case Report A 19-year-old girl presented with a 14-year history of myoclonus and dystonia that severely affected her left arm, neck, and trunk. Genetic studies showed a mutation in SGCE [deletion in exon 6 (c.771_772delAT, Cys258X)]. Both myoclonus and dystonia responded to anticholinergic treatment for 7 years and improved spontaneously. Conclusions The possibility of spontaneous improvement should be kept in mind when considering the therapeutic strategy in myoclonus-dystonia patients, especially when contemplating deepbrain stimulation. KCI Citation Count: 6 |
| Author | Lee, Jae Hyeok Lyoo, Chul Hyoung Lee, Myung Sik |
| AuthorAffiliation | a Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea b Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea |
| AuthorAffiliation_xml | – name: a Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea – name: b Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea |
| Author_xml | – sequence: 1 givenname: Jae Hyeok surname: Lee fullname: Lee, Jae Hyeok organization: Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea – sequence: 2 givenname: Chul Hyoung surname: Lyoo fullname: Lyoo, Chul Hyoung organization: Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea – sequence: 3 givenname: Myung Sik surname: Lee fullname: Lee, Myung Sik organization: Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22259621$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001619433$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNqFkb1v1DAYhy1URK-FnQllgyXBdpw4XpBOB5STikDlmC2fY_fcJnZqO63y39dpyucAk4f39-H3eU_AkXVWAfASwaJkTfP2StoCQ4QKWpACl-gJWGEIq7yCqDwCK0TLJq-rpj4GJyFcQVhT2KBn4BhjXLEaoxWY1tlXEY2yMbsz8ZCdKauikaLrpmzjrDa-V232eXKyc3YM-fspRGeNyC5UGJxt0zC6bG2T5-A6Y5W_NDLbeSViP4cK22bbfvDuNim_JUcUVrkxdNNz8FSLLqgXj-8p-P7xw27zKT__crbdrM9zSXATc6qg3rfNnglVaq1bWRPWwhLpRlCClSJtBTGFDAsqSE0UYRWtK93WmkkI1b48BW-WXOs1v5aGO2Ee3kvHrz1fX-y2HDeIoipJ0SId7SCmuwSBD970wk8cQT4T54k4n4lzyglPxJPn3eIZxn1CJdPSXvzyzWV_Tqw5pOpbXqYTEMZSwOvHAO9uRhUi702QqusWUJzNX6NlNVe9-r3qZ8ePayZBvQikdyF4pbk0MV3Xzc2m-9cS8C_jf_e-B0cuyDY |
| CitedBy_id | crossref_primary_10_1111_febs_16106 crossref_primary_10_1002_mds_27822 crossref_primary_10_1016_j_parkreldis_2020_06_016 crossref_primary_10_1007_s12035_016_9712_x crossref_primary_10_1007_s40120_020_00186_4 crossref_primary_10_1002_mdc3_13883 crossref_primary_10_1016_j_parkreldis_2018_05_005 crossref_primary_10_3390_cells13181520 crossref_primary_10_1186_s13052_021_00986_w |
| Cites_doi | 10.1097/00002826-198406000-00004 10.1007/BF00298440 10.1002/mds.22375 10.1002/mds.22425 10.1212/01.wnl.0000297516.98574.c0 10.1212/WNL.37.4.608 |
| ContentType | Journal Article |
| Copyright | Copyright © 2011 Korean Neurological Association 2011 |
| Copyright_xml | – notice: Copyright © 2011 Korean Neurological Association 2011 |
| DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY ACYCR |
| DOI | 10.3988/jcn.2011.7.4.231 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | A Patient with Genetically Confirmed Myoclonus-Dystonia Responded to Anticholinergic Treatment and Improved Spontaneously |
| EISSN | 2005-5013 |
| EndPage | 232 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_281715 10.3988/jcn.2011.7.4.231 PMC3259499 22259621 10_3988_jcn_2011_7_4_231 |
| Genre | Journal Article |
| GroupedDBID | 29K 2WC 5-W 5GY 8JR 8XY 9ZL AAKDD AAYXX ACYCR ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION D-I DIK DU5 E3Z EF. F5P GROUPED_DOAJ HYE KQ8 M48 OK1 PGMZT RPM NPM 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c428t-7e0fbd8b9ae3fffdc649d031f8a742ee4d5027092a7a464e495765fd6f9c00eb3 |
| IEDL.DBID | M48 |
| ISSN | 1738-6586 2005-5013 |
| IngestDate | Sun Mar 09 07:51:56 EDT 2025 Sun Oct 26 03:50:03 EDT 2025 Thu Aug 21 17:57:16 EDT 2025 Fri Jul 11 16:53:18 EDT 2025 Thu Apr 03 07:08:25 EDT 2025 Tue Jul 01 03:10:45 EDT 2025 Thu Apr 24 23:07:12 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | myoclonus spontaneous remission anticholinergics dystonia |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c428t-7e0fbd8b9ae3fffdc649d031f8a742ee4d5027092a7a464e495765fd6f9c00eb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-002236.2011.7.4.003 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3988/jcn.2011.7.4.231 |
| PMID | 22259621 |
| PQID | 917157351 |
| PQPubID | 23479 |
| PageCount | 2 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_281715 unpaywall_primary_10_3988_jcn_2011_7_4_231 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3259499 proquest_miscellaneous_917157351 pubmed_primary_22259621 crossref_citationtrail_10_3988_jcn_2011_7_4_231 crossref_primary_10_3988_jcn_2011_7_4_231 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-12-01 |
| PublicationDateYYYYMMDD | 2011-12-01 |
| PublicationDate_xml | – month: 12 year: 2011 text: 2011-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Journal of clinical neurology (Seoul, Korea) |
| PublicationTitleAlternate | J Clin Neurol |
| PublicationYear | 2011 |
| Publisher | Korean Neurological Association 대한신경과학회 |
| Publisher_xml | – name: Korean Neurological Association – name: 대한신경과학회 |
| References | Kinugawa (10.3988/jcn.2011.7.4.231_ref2) 2009; 24 Chokroverty (10.3988/jcn.2011.7.4.231_ref7) 1987; 37 Roze (10.3988/jcn.2011.7.4.231_ref3) 2008; 70 Luciano (10.3988/jcn.2011.7.4.231_ref4) 2009; 24 Pueschel (10.3988/jcn.2011.7.4.231_ref6) 1992; 8 Asmus (10.3988/jcn.2011.7.4.231_ref1) 2004; 94 Duvoisin (10.3988/jcn.2011.7.4.231_ref5) 1984; 7 19133653 - Mov Disord. 2009 Feb 15;24(3):425-8 19117361 - Mov Disord. 2009 Mar 15;24(4):479-89 18362280 - Neurology. 2008 Mar 25;70(13):1010-6 14509663 - Adv Neurol. 2004;94:113-9 6733693 - Clin Neuropharmacol. 1984;7(2):141-7 1591746 - Childs Nerv Syst. 1992 Mar;8(2):61-6 3561772 - Neurology. 1987 Apr;37(4):608-15 |
| References_xml | – volume: 7 start-page: 141 year: 1984 ident: 10.3988/jcn.2011.7.4.231_ref5 publication-title: Clin Neuropharmacol doi: 10.1097/00002826-198406000-00004 – volume: 8 start-page: 61 year: 1992 ident: 10.3988/jcn.2011.7.4.231_ref6 publication-title: Childs Nerv Syst doi: 10.1007/BF00298440 – volume: 24 start-page: 425 year: 2009 ident: 10.3988/jcn.2011.7.4.231_ref4 publication-title: Mov Disord doi: 10.1002/mds.22375 – volume: 24 start-page: 479 year: 2009 ident: 10.3988/jcn.2011.7.4.231_ref2 publication-title: Mov Disord doi: 10.1002/mds.22425 – volume: 70 start-page: 1010 year: 2008 ident: 10.3988/jcn.2011.7.4.231_ref3 publication-title: Neurology doi: 10.1212/01.wnl.0000297516.98574.c0 – volume: 94 start-page: 113 year: 2004 ident: 10.3988/jcn.2011.7.4.231_ref1 publication-title: Adv Neurol – volume: 37 start-page: 608 year: 1987 ident: 10.3988/jcn.2011.7.4.231_ref7 publication-title: Neurology doi: 10.1212/WNL.37.4.608 – reference: 18362280 - Neurology. 2008 Mar 25;70(13):1010-6 – reference: 19133653 - Mov Disord. 2009 Feb 15;24(3):425-8 – reference: 1591746 - Childs Nerv Syst. 1992 Mar;8(2):61-6 – reference: 14509663 - Adv Neurol. 2004;94:113-9 – reference: 3561772 - Neurology. 1987 Apr;37(4):608-15 – reference: 6733693 - Clin Neuropharmacol. 1984;7(2):141-7 – reference: 19117361 - Mov Disord. 2009 Mar 15;24(4):479-89 |
| SSID | ssj0067081 |
| Score | 1.9545321 |
| Snippet | The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases.... Background The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in... |
| SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 231 |
| SubjectTerms | Case Report 신경과학 |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLVYJ8FeuMPKTUbiBaS0aZybH6uVakxqVbFVGk-W48sojZwqTYTCr-ezk1ZUQyB4yoPtWnaP7XPs74LQu0BTX0ZaeCTQIFBUKL1UydiLIyJjQiKdunQ-s3l8vgwvrqPrzou_s6oE4vNNGLdLXzaGb7ZqOOEVHy4mU_e1D2EXZ_MhVPISD_jJYCP1ETqOI2DjPXS8nC_GX5wfJKxlOGBdfjkbcDMCutO-VBIKus924kJ4JoNwEJDRwcl0ZEr9O9J523byXm02vPnO8_yXg2n6APGde09rj7Ie1FU2ED9uR3v87zE_RPc71orHLcweoTvKPEZ3Z927_BPUjPGiDdCK7cUutsGs3SV53mDrU7gqYSx41hQiL0y99SaN5Zwrjj87E10JhVWBx8Z6gdksQqqEDRlf7YzgMTcSt9cfUPMSWgClVUW9zZunaDn9eHV27nVJHTwBSqfyEuXrTKYZ5YporaWIQyphZ9EpB5WuACwRKGWfBjzhYQzgoaCIIi1jTYXvg_R_hnqmMOoU4TQcaclDQRICsjCLaUgDrYHhERIoEdI-Gu7-UCa6iOc28UbOQPlYCDCYTmYhwBIWMpjVPnq_b7Fpo338oe5bwAhbixWzIbrt96Zg65KBEPnEgnSUjKI-wjsEMVi29i2mnR5GbXFCIviZ5y2g9h1aBU7jAEqSA6jtK9juDkvM6quLDE6gJUjYPvqwB-Vfx_HiXyq_RCfuUt3Z87xCvaqs1WtgZVX2plt4PwFLaTYe priority: 102 providerName: Unpaywall |
| Title | A Patient with Genetically Confirmed Myoclonus-Dystonia Responded to Anticholinergic Treatment and Improved Spontaneously |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22259621 https://www.proquest.com/docview/917157351 https://pubmed.ncbi.nlm.nih.gov/PMC3259499 http://www.thejcn.com/Synapse/Data/PDFData/0145JCN/jcn-7-231.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001619433 |
| UnpaywallVersion | publishedVersion |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Clinical Neurology, 2011, 7(4), , pp.231-232 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2005-5013 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067081 issn: 1738-6586 databaseCode: KQ8 dateStart: 20050101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2005-5013 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067081 issn: 1738-6586 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2005-5013 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067081 issn: 1738-6586 databaseCode: DIK dateStart: 20050101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2005-5013 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067081 issn: 1738-6586 databaseCode: 5-W dateStart: 20050101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2005-5013 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067081 issn: 1738-6586 databaseCode: RPM dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2005-5013 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0067081 issn: 1738-6586 databaseCode: M48 dateStart: 20050401 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA66C7ov4n3rZYjgi0LHtkmT5kFkUJdVmGXRHVifQiYXHbeka2cG7b_3pO1UBwcFn_qQG813kpzvnOQchJ5mTiQmdzommQOCYqmJC2tYzHJiGCG5K9p0PtMTdjyj78_z81_Po_sJXO6kdiGf1Kwuxz--Na9gwb8MjFMAgfuqfReLk4_pOAuPqvfhnBIhkcOUDj4FxpM2ZWnKYYnDuds7LXf2EEIEg6ALlqVb59VVX7tdquifNyqvr_2lar6rsvztuDq6iW70eiaedIJxC12x_ja6Nu096XdQM8GnXUhVHEyxOISfbs3aZYPDK8BFDePgaVPpsvLrZfymCVriQuEP7aVaA4WrCk98eLcV8v7YGrZQfLa5to6VN7gzWEDNj9AClFBbrZdlcxfNjt6evT6O-zQMsQZusoq5TdzcFHOhLHHOGc2oMLAXuEIBr7YAbw7cNhGZ4ooygFsAh8mdYU7oJAGyfg_t-crbQ4QLmjqjqCacAJGbM0FF5hzoZIRkVlMRoRebyZa6j1EeUmWUErhKQEoCUjIgJbmkEpCK0LOhxWUXn-MvdZ8AfvJCL2QIqh2-nyt5UUugDu9kVqQ8zSOEN-hKWGjBe9JNjxShmJMcurnfgT0MuJGVCPEtMRgqhOG2S_ziSxvLm0BLIJ0Rej4IzD__48F_D_MQHbQ28fY6ziO0t6rX9jEoVav5qDVGjNoVM0L7s5PTyaefbH4j-w |
| linkProvider | Scholars Portal |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLVYJ8FeuMPKTUbiBaS0aZybH6uVakxqVbFVGk-W48sojZwqTYTCr-ezk1ZUQyB4yoPtWnaP7XPs74LQu0BTX0ZaeCTQIFBUKL1UydiLIyJjQiKdunQ-s3l8vgwvrqPrzou_s6oE4vNNGLdLXzaGb7ZqOOEVHy4mU_e1D2EXZ_MhVPISD_jJYCP1ETqOI2DjPXS8nC_GX5wfJKxlOGBdfjkbcDMCutO-VBIKus924kJ4JoNwEJDRwcl0ZEr9O9J523byXm02vPnO8_yXg2n6APGde09rj7Ie1FU2ED9uR3v87zE_RPc71orHLcweoTvKPEZ3Z927_BPUjPGiDdCK7cUutsGs3SV53mDrU7gqYSx41hQiL0y99SaN5Zwrjj87E10JhVWBx8Z6gdksQqqEDRlf7YzgMTcSt9cfUPMSWgClVUW9zZunaDn9eHV27nVJHTwBSqfyEuXrTKYZ5YporaWIQyphZ9EpB5WuACwRKGWfBjzhYQzgoaCIIi1jTYXvg_R_hnqmMOoU4TQcaclDQRICsjCLaUgDrYHhERIoEdI-Gu7-UCa6iOc28UbOQPlYCDCYTmYhwBIWMpjVPnq_b7Fpo338oe5bwAhbixWzIbrt96Zg65KBEPnEgnSUjKI-wjsEMVi29i2mnR5GbXFCIviZ5y2g9h1aBU7jAEqSA6jtK9juDkvM6quLDE6gJUjYPvqwB-Vfx_HiXyq_RCfuUt3Z87xCvaqs1WtgZVX2plt4PwFLaTYe |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Patient+with+Genetically+Confirmed+Myoclonus-Dystonia+Responded+to+Anticholinergic+Treatment+and+Improved+Spontaneously&rft.jtitle=Journal+of+clinical+neurology+%28Seoul%2C+Korea%29&rft.au=Lee%2C+Jae+Hyeok&rft.au=Lyoo%2C+Chul+Hyoung&rft.au=Lee%2C+Myung+Sik&rft.date=2011-12-01&rft.pub=Korean+Neurological+Association&rft.issn=1738-6586&rft.eissn=2005-5013&rft.volume=7&rft.issue=4&rft.spage=231&rft.epage=232&rft_id=info:doi/10.3988%2Fjcn.2011.7.4.231&rft_id=info%3Apmid%2F22259621&rft.externalDocID=PMC3259499 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6586&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6586&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6586&client=summon |